myTomorrows raises €25.0M Series C round
11 November 2025· Amsterdam, The Netherlands· health, digital_health, ai, pure_software, b2b, clinical_trials_access
The funding is to accelerate how emerging therapies reach the patients who need them most, scale its AI-powered platform that connects patients, physicians, clinical trial sites, and BioPharma partners, and expand its global platform for accessing experimental treatments.
Investors
LeadAvego Healthcare Capital
About myTomorrows
Key People
Michel van HartenCEO
Marshall van BeurdenCTO
Vanessa LemariéChief Operating Officer
Ronald BrusFounder
Stage
Series C
Headquarters
Amsterdam, The Netherlands
Founded
2012
Team Size
51–200
Sectors
healthdigital_healthaipure_softwareb2bclinical_trials_access